NCT01625260 2024-07-19
A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer
Altor BioScience
Phase 1/2 Terminated
Altor BioScience
Aravive, Inc.
University Hospital Southampton NHS Foundation Trust
Lumos Pharma
Sun Yat-sen University
Clovis Oncology, Inc.
Rigshospitalet, Denmark
University of Kentucky
University of Illinois at Chicago
Women and Infants Hospital of Rhode Island